Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.

Public markets

Biocytogen Pharmaceuticals, a China-based antibody drug discovery platform developer backed by insurer China Life, has listed on the Hong Kong Stock Exchange’s Main Board. The company is set to secure about HK$471m ($60m) in net proceeds having issued nearly 21.8 million shares at HK$25.22 apiece.

Funding

Company Company description Sector Country Round Round size($m) Deal date Investors
JenaValve Technology Differentiated transcatheter aortic valve replacement system manufacturer Healthcare US C 100 31/08/2022 Peijia Medical; Bain Capital Life Sciences (lead), Andera Partners, Valiance Advisors, Gimv,  Cormorant Asset Management, RMM, Venture Incubator, Pictet Alternative…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Events
GCV Institute: CVC Investment Programs
Dec 3 -
Dec 4, 2024
Online
Events
GCV Connect: Korea 2024
Dec 10 -
Dec 12, 2024
Seoul (South Korea)
Events
GCV Institute: CVC Investment Programs
Jan 28 -
Jan 29, 2025
Online
Events
GCV Institute: CVC Investment Programs
Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)
Events
GCVI Summit 2025
Mar 18 -
Mar 20, 2025
Monterey, CA (USA)
Events
GCV Institute: Landing the Value of Corporate Venturing
May 1 -
May 6, 2025
Online
Events
GCV Symposium 2025
Jun 17 -
Jun 19, 2025
London (UK)
© 2024 Mawsonia Ltd. All rights reserved.
test reg